AU2887195A - Kit for pretargeting and novel pretargeting conjugates - Google Patents
Kit for pretargeting and novel pretargeting conjugatesInfo
- Publication number
- AU2887195A AU2887195A AU28871/95A AU2887195A AU2887195A AU 2887195 A AU2887195 A AU 2887195A AU 28871/95 A AU28871/95 A AU 28871/95A AU 2887195 A AU2887195 A AU 2887195A AU 2887195 A AU2887195 A AU 2887195A
- Authority
- AU
- Australia
- Prior art keywords
- pretargeting
- conjugates
- kit
- novel
- novel pretargeting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
- A61K47/665—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
- A61K47/6897—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Optics & Photonics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94201826 | 1994-06-24 | ||
EP94201826 | 1994-06-24 | ||
PCT/EP1995/002425 WO1996000087A2 (en) | 1994-06-24 | 1995-06-22 | Kit for pretargeting and novel pretargeting conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2887195A true AU2887195A (en) | 1996-01-19 |
Family
ID=8216990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28871/95A Abandoned AU2887195A (en) | 1994-06-24 | 1995-06-22 | Kit for pretargeting and novel pretargeting conjugates |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2887195A (en) |
WO (1) | WO1996000087A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020082979A (en) * | 2001-04-24 | 2002-11-01 | 이명철 | vagina contract pressure gauge |
KR101541764B1 (en) * | 2012-02-24 | 2015-08-05 | (주)알테오젠 | Antibody variant with cysteine residues, antibody-drug conjugate comprising the antibody variant, and method of manufacturing thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK608589D0 (en) * | 1989-12-01 | 1989-12-01 | Holm Arne | CHEMICAL PROCEDURE |
EP0564592B1 (en) * | 1990-12-21 | 1999-10-13 | The Rockefeller University | Liver enriched transcription factor |
EP0590109A4 (en) * | 1992-03-04 | 1995-04-19 | Akzo Nv | -i(IN VIVO) BINDING PAIR PRETARGETING. |
EP0650735A3 (en) * | 1993-07-09 | 1999-04-14 | Akzo Nobel N.V. | Kit and method for pretargeting |
-
1995
- 1995-06-22 WO PCT/EP1995/002425 patent/WO1996000087A2/en active Application Filing
- 1995-06-22 AU AU28871/95A patent/AU2887195A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1996000087A2 (en) | 1996-01-04 |
WO1996000087A3 (en) | 1996-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7101094A (en) | Factor ix - polymeric conjugates | |
AU6029594A (en) | Factor viii - polymeric conjugates | |
AU3304795A (en) | Bisresorcinyltriazines | |
AU2832295A (en) | Cytoanalyzer | |
AU2341097A (en) | Music composition | |
AU3304995A (en) | 2-Hydroxyphenyltriazines | |
AU3308195A (en) | Antihypertriglyceridemic composition | |
AU2837895A (en) | Thiazine- or thiazepine-derivatives | |
AU4131596A (en) | Polyglycomers | |
AU4044795A (en) | Handleset | |
AU4344696A (en) | Oligonucleotide-dendrimer conjugates | |
AU2308295A (en) | Heterocyclylbenzonitriles | |
AU1963395A (en) | Boom-structure | |
AU4029295A (en) | Thienopyridones | |
AU3166195A (en) | Acylimidazopyridines | |
AU3666795A (en) | Macerator | |
AU4590996A (en) | Boekomslag | |
AU2887195A (en) | Kit for pretargeting and novel pretargeting conjugates | |
AU2813195A (en) | Composition | |
AU3166095A (en) | Benzylimidazopyridines | |
AU2411395A (en) | Hydrocopter | |
AU3446995A (en) | Biodestumping | |
AU1603595A (en) | Meso-azanoradamantanes | |
AU3291295A (en) | Composition | |
AU3417395A (en) | Hydro-ethano-indeno-pyridines |